BamSEC and AlphaSense Join Forces
Learn More

Aura Biosciences Inc.

NASDAQ: AURA    
Share price (8/19/25): $6.40    
Market cap (8/19/25): $398 million
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.2
from 8-K 18 pages Form of Warrant to Purchase Common Stock
12/34/56
EX-4.1
from 8-K 17 pages The Issuer Has Filed a Registration Statement (Including a Prospectus) With the SEC for the Offering to Which This Communication Relates. Before You Invest, You Should Read the Prospectus in That Registration Statement and Other Documents the Issuer Has Filed With the SEC for More Complete Information About the Issuer and This Offering. You May Get These Documents for Free by Visiting Edgar on the SEC Web Site at WWW.SEC.GOV. Form of Pre-Funded Warrant to Purchase Common Stock
12/34/56
EX-4.1
from 10-K 5 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.6
from S-3 40 pages Aura Biosciences, Inc. Issuer and [Trustee], Trustee Indenture Dated as of [•], 202[•] Subordinated Debt Securities
12/34/56
EX-4.5
from S-3 39 pages Aura Biosciences, Inc. Issuer and [Trustee], Trustee Indenture Dated as of [•], 202[•] Senior Debt Securities
12/34/56
EX-4.1
from 10-K 5 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4
from 10-K 5 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.6
from S-3 40 pages Aura Biosciences, Inc. Issuer and [Trustee], Trustee Indenture Dated as of [•], 202[•] Subordinated Debt Securities
12/34/56
EX-4.5
from S-3 39 pages Aura Biosciences, Inc. Issuer and [Trustee], Trustee Indenture Dated as of [•], 202[•] Senior Debt Securities
12/34/56
EX-4.1
from 10-K 5 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.1
from S-1/A 2 pages Indenture or similar
12/34/56
EX-4.2
from S-1 81 pages Aura Biosciences, Inc. Fifth Amended and Restated Investors’ Rights Agreement March 18, 2021
12/34/56
EX-4.2
from DRS 81 pages Aura Biosciences, Inc. Fifth Amended and Restated Investors’ Rights Agreement March 18, 2021
12/34/56